This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Other. Active years: 2004-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 834,513 Years Active: 2004-2009
Title: Innovations in Antitumor Agents by Tomohiro Sawa
Introduction
Tomohiro Sawa is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of oncology through his innovative work on antitumor agents. With a total of 3 patents, Sawa's research focuses on developing effective treatments for cancer.
Latest Patents
Sawa's latest patents include groundbreaking advancements in antitumor agents. One of his notable inventions is an antitumor agent that combines an oxidoreductase, such as xanthine oxidase, chemically conjugated to a polymer like polyethylene glycol. This combination allows for initial administration and accumulation in tumor tissue, followed by the administration of a substrate for the oxidoreductase, which releases reactive oxygen species. This innovative approach results in improved tumor-selective cytotoxic activity.
Another significant patent is for anticancer agents that contain as the active ingredient a heme oxygenase inhibitory metalloporphyrin derivative. This derivative is conjugated with amphipathic or water-soluble polymers, particularly Zn-protoporphyrin (ZnPP) conjugated with polyethylene glycol. The conjugation to these polymers enables intravenous administration and enhances the anticancer effect through tumor-selective delivery.
Career Highlights
Throughout his career, Tomohiro Sawa has focused on developing novel therapeutic strategies for cancer treatment. His work has been recognized for its potential to improve patient outcomes and provide more effective treatment options.
Collaborations
Sawa has collaborated with esteemed colleagues in his field, including Hiroshi Maeda and Takaaki Akaike. These collaborations have contributed to the advancement of his research and the development of innovative cancer therapies.
Conclusion
Tomohiro Sawa's contributions to the field of oncology through his innovative antitumor agents highlight the importance of research in developing effective cancer treatments. His work continues to pave the way for advancements in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile